PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 3, entitled, “GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.”
Aging (Aging-US) Authors
![Figure 7. Schematic diagram illustrates the process whereby IL-17 treatment promotes IL-18 production in OASFs [osteoarthritis synovial fibroblasts].](https://aging-us.net/wp-content/uploads/2024/02/Screen-Shot-2024-02-13-at-11.52.53-AM-800x600.png)
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 2, entitled, “IL-17 promotes IL-18 production via the MEK/ERK/miR-4492 axis in osteoarthritis synovial fibroblasts.”
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 2, entitled, “PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.”
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 2, entitled, “Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation.”
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 2, entitled, “Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma.”
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.”
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.”
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.”
PRESS RELEASE: On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., published a new brief report in Oncoscience, entitled, “My battle with cancer. Part 1.”
PRESS RELEASE: On January 11, 2024, a new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.”